04 Jun 2022
byElaine Soliven
Daily use of somatropin, a recombinant human growth hormone (rhGH), led to significantly improved growth outcomes, particularly height standard deviation scores (HT-SDSs), in prepubertal children with idiopathic short stature (ISS), according to a recent study.